Results 31 to 40 of about 2,965 (169)
Tofacitinib for Prurigo Nodularis: A Case Report
Changlan Peng,1 Chunxiao Li,2 Yingying Zhou,1 Qiuyue Wang,1 Ping Xie,1 Tianhao Li,2,* Pingsheng Hao2,* 1Department of Dermatology, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Dermatology,
Peng C +6 more
doaj
We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.
Keiji Kosaka +3 more
doaj +1 more source
Successful Treatment of Recalcitrant Prurigo with Alitretinoin [PDF]
BACKGROUND Chronic itch with secondary scratch lesions such as prurigo has a major impact on quality of life. Due to its relapsing nature and often unknown origin, its treatment is challenging.
Gadaldi, Karolina +5 more
core +3 more sources
Startups Driving Artificial Intelligence Into Clinical Dermatology
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest +10 more
wiley +1 more source
Prurigo pigmentosa is an infrequent inflammatory dermatosis of unknown etiology, characterized by recurrent episodes of pruritic erythematous papules which develop into intense reticulated pigmentation. It has been referenced most frequently in young women in Japan. Only thirty cases have been described outside of Japan.
Eloy, Rodríguez-Díaz +5 more
openaire +2 more sources
Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France
Background Chronic prurigo or prurigo nodularis is a severe condition with chronic pruritus and skin lesions. Current unnmet medical needs are numerous and generate a significant burden for the patients.
Laurent Misery +6 more
doaj +1 more source
ImportancePrurigo nodularis (PN) is a chronic heterogeneous inflammatory skin disease.ObjectiveTo elucidate which components of type 2 inflammation are dysregulated systemically in PN.DesignWhole blood was obtained from PN patients with uncontrolled ...
Varsha Parthasarathy +10 more
doaj +1 more source
This review synthesizes epidemiological evidence linking atopic dermatitis to attention‐deficit/hyperactivity disorder in children, proposes an “inflammation‐itch‐neurobehavioral axis” integrating sleep disruption, neuroendocrine dysregulation, and emerging neuro‐immune circuits, and outlines multidisciplinary management strategies targeting both skin ...
Qingyang Zhao +11 more
wiley +1 more source
The Origins of Allergy: An Outside‐In, Bioenergetic Hypothesis
ABSTRACT Allergic disease has risen too rapidly for inherited susceptibility to explain it, and the risk variants so far reported lie in the epithelial barrier and in type‐2 immunity. We propose a five‐layer model in which epithelial barrier and bioenergetic dysfunction may precede and promote type‐2 immune deviation rather than arise solely as its ...
Peter K. Smith +9 more
wiley +1 more source
PRURIGO COMO MARCADOR CUTÂNEO DE INFECÇÃO PELO HTLV
Introdução: O prurigo ainda não foi definitivamente associado à infecção pelo HTLV. Entretanto, há relatos de casos com aparecimento dessas lesões anos antes de surgimento de Leucemia Linfoma de Células T do Adulto(LLTA), como pródromo da neoplasia ...
Tiago Silveira-Lima +3 more
doaj +1 more source

